Molecular Partners Statistics
NASDAQ: MOLNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.53-0.14 (-5.25%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Molecular Partners by the numbers
Molecular Partners has a market capitalization of $96.8 million based on 38.34M shares outstanding. With trailing EPS of $-1.68, Molecular Partners is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.8% below its 50-day average and 38.1% below its 200-day average.
Average daily trading volume is 1.63K shares, or about $4,126 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MOLN valuation vs. peer median
| Metric | MOLN | Peer median | Difference |
|---|---|---|---|
| Market cap | $96.80M | $95.83M | +1% |
| Avg. volume | 1.63K | 1.05M | -100% |
Peer median across 8 companies: IPHA, VYGR, OTLK, LENZ, ZURA, CRDL, FATE, ARMP.
Valuation
- Market cap
- $96.80M
- EPS (TTM)
- $-1.68
- Shares outstanding
- 38.34M
Price and trading
- Previous close
- 2.67
- Open
- 2.53
- Day range
- 2.53 – 2.53
- 52-week range
- 2.52 – 5.36
- 52-week change
- -37.50%
- Beta
- —
- Volume
- 928
- Average volume
- 1.63K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 25, 2026
Additional statistics
- Market Cap
- 96.80M
- Forward Pe
- -19.63
- Eps
- -1.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.36
- Week52 Low
- 2.52
- Avg Volume
- 1,634.00
- Shares Outstanding
- 38.34M
- Ma50
- 3.60
- Ma200
- 4.08
- Earnings Date
- Aug 25, 2026
- Pct From52w High
- -52.89%
- Pct From52w Low
- 0.20%